Young Women and HIV: Farieda’s Story

Farieda was 17, a student, and already a mom. At 16, she became pregnant, left her grandfather’s home, and found safety
at a shelter that did more than give her a bedit gave her a plan. “I really want to make the best of my life,” she said.
“I’m going to finish school, so I can give myself and my child a better future.”

That’s the part of Farieda’s story that sticks: not tragedy, but momentum. And it’s also the perfect doorway into a topic
that too often gets treated like a pop quiz everyone’s afraid to takeHIV, especially among young women.

This article uses Farieda’s journey as a guide to something bigger: why adolescent girls and young women face unique HIV risks,
what the data says (including in the United States), what prevention looks like in real life, and what it means to live well
with HIV today. We’ll keep it accurate, practical, and yeshuman. Because HIV isn’t a morality tale. It’s a virus. And viruses
are famously uninterested in your good intentions.

Farieda’s turning point: safety, support, and a future that isn’t “optional”

Farieda connected with a program designed for at-risk girls and young womensupporting them with housing, education, and
sexual and reproductive health services. That combination matters because HIV risk doesn’t happen in a vacuum. Poverty,
gender inequality, limited access to health care and education, and gender-based violence can all raise risk. When life is
unstable, prevention toolstesting, condoms, PrEP, medical visitscan feel like “extras” instead of essentials.

Farieda’s story highlights a key truth: reducing HIV risk for young women isn’t only about biology or behavior. It’s about
power, safety, and options. A safe place to sleep is prevention. Staying in school is prevention. Being able to say “no,”
or to insist on protection, is prevention. That’s why community programs and youth-centered services aren’t “nice to have.”
They’re part of the HIV prevention toolkit.

Why young women face unique HIV risks

1) Biology can tilt the odds

HIV transmission risk isn’t the same for every type of exposure. For people who have receptive vaginal sex, biological factors
can increase vulnerabilityespecially if there are untreated sexually transmitted infections (STIs), inflammation, or tissue
irritation. That doesn’t mean young women are “doomed.” It means prevention needs to be realistic about how bodies work,
not just how people wish they worked on a Saturday night.

2) Relationships aren’t always equal

Many young women are in relationships where there’s an age gap, a financial imbalance, or pressure to keep the peace.
Negotiating condoms or discussing HIV status can feel riskyemotionally, physically, or economically. If someone fears
rejection, violence, or losing housing, “just use protection” becomes less of a slogan and more of a high-stakes negotiation.

3) Violence and coercion raise risk

Sexual violence and coercion increase HIV risk directly (through forced exposure) and indirectly (through trauma,
reduced ability to negotiate protection, and barriers to health care). If that’s part of someone’s experience, prevention
should include access to emergency services like post-exposure prophylaxis (PEP), along with trauma-informed care.

4) Stigma is a stealthy barrier

Young women often carry an extra backpack of stigma: “If I ask for an HIV test, people will think…” “If I take PrEP,
someone will judge me…” Stigma turns routine health care into a performance review nobody asked for. The result:
delayed testing, less prevention, more anxietyand none of that helps anyone stay HIV-negative or get treated early.

The U.S. snapshot: what the numbers say (and what they don’t)

In the United States, women are a smaller share of new HIV diagnoses than men, but the impact is far from smallespecially
for Black women and women in the South. Data from recent CDC updates show that in 2023, females accounted for about 19% of
HIV diagnoses in the U.S. And within that, Black/African American females represented about half of diagnoses among females,
despite being a smaller share of the overall female population.

Zoom out and you see more pattern than randomness. The South continues to carry a high share of diagnoses. Structural factors
play a role: access to health care, insurance coverage, transportation, stigma, and local prevention infrastructure.
This is why HIV isn’t just a medical issueit’s a systems issue.

The hopeful news: national estimates show new HIV infections have been trending downward in recent years, with a notable
decline among young people. Progress is linked to a mix of strategiesmore testing, more people on effective treatment
(meaning less transmission), and wider use of prevention tools like PrEP. Translation: the science works when people can
actually access it.

HIV transmission: a quick myth-busting pit stop

Let’s clear the air. HIV is transmitted through specific body fluidsprimarily blood, semen, vaginal fluids, rectal fluids,
and breast milkwhen they enter the bloodstream (or contact certain mucous membranes) in a way that allows transmission.
The most common routes are sex without protection, sharing injection equipment, and perinatal transmission when a pregnant
person isn’t treated.

HIV is not transmitted by casual contact: hugging, sharing food, using the same toilet, or sitting next to
someone who has great taste in music. (And if someone tells you otherwise, you can gently place them back in 1987.)

Prevention that fits real life: a practical playbook for young women

Condoms: still undefeated for “two-for-one” protection

Condoms reduce the risk of HIV and also help prevent many other STIs. That matters because other STIs can increase HIV
susceptibility. Condoms aren’t about “trust issues.” They’re about health. You can trust someone and still wear a seatbelt.

PrEP: prevention you can control

Pre-exposure prophylaxis (PrEP) is medication for people who are HIV-negative that dramatically reduces the risk of getting
HIV when taken as prescribed. Think of it as a safety net you wearquietly powerful, no dramatic speeches required.

For cisgender women, major clinical guidance has long emphasized options that are proven for receptive vaginal sex, including
daily oral PrEP with tenofovir disoproxil fumarate/emtricitabine (often referred to as TDF/FTC). Injectable options have also
expanded access for people who don’t want (or can’t manage) a daily pill.

Important nuance (because your body deserves nuance): emtricitabine/tenofovir alafenamide (Descovy) has not been established
for HIV prevention in people at risk through receptive vaginal sex, so it is generally not the go-to PrEP option for
cisgender women whose primary risk is vaginal exposure.

Newer options are changing the game even further. In 2025, a twice-yearly injectable PrEP option (lenacapavir, branded as
Yeztugo) received FDA approval for HIV prevention, offering an alternative for people who want longer-interval dosing.
Like all PrEP options, it comes with requirements: confirming HIV-negative status before starting and at follow-up,
sticking to the dosing schedule, and pairing PrEP with other prevention measures for the best protection.

PEP: the “oh no” button (but it has a deadline)

Post-exposure prophylaxis (PEP) is emergency medication taken after a potential HIV exposure. The rule is simple:
start as soon as possible, and definitely within 72 hoursafter that, it won’t work.
PEP is usually taken for 28 days.

If someone has been sexually assaulted, PEP can be part of urgent care. It should be offered quickly, without judgment,
and alongside supportive services. You don’t have to “prove” you deserve protection.

Testing: make it routine, not dramatic

HIV testing is recommended for everyone at least once between ages 13 and 64, with more frequent testing for people with
ongoing risk. Testing is also recommended during pregnancy, and many clinical bodies support universal screening in prenatal care.

Testing is not an accusation. It’s information. And information is what lets you choose the right next stepwhether that’s
reassurance, PrEP, treatment, or repeat testing after a window period. Different test types detect HIV at different times
after exposure; if you test too early, you may need a repeat test. A clinician or local testing site can help you pick the
right test and timing.

Pregnancy and HIV: protecting two futures at once

Farieda’s story includes pregnancya reality for many adolescents and young women. Pregnancy is exactly when HIV prevention
and care become even more important, not less.

In the U.S., clinical guidance supports routine HIV testing in pregnancy (often early, and sometimes again later in pregnancy
depending on risk and local recommendations). If a pregnant person has HIV, effective antiretroviral treatment dramatically
reduces the risk of perinatal transmission. If a pregnant person is HIV-negative but at risk, PrEP may be considered as part
of preventionespecially when risk is ongoing.

The big message: pregnancy is not a reason to avoid care. It’s a reason to get excellent care.

Living with HIV today: modern reality is not the old stereotype

HIV treatment has advanced enormously. People living with HIV who take antiretroviral therapy (ART) consistently can achieve
viral suppressionmeaning the amount of virus in the blood becomes so low that tests can’t detect it.

Here’s the headline that deserves to be on a billboard: Undetectable = Untransmittable (U=U).
When a person maintains an undetectable viral load on treatment, there is effectively zero risk of sexually transmitting HIV
to partners. This is not wishful thinking; it’s evidence-based science. U=U changes relationships, family planning, mental health,
and the entire conversation about HIV.

For young women living with HIV, that means life goals don’t have to shrink. Relationships, college, career, parenthood
these are still on the table. The medical focus becomes: staying in care, taking medication as prescribed, monitoring labs,
and addressing whole-person health (including mental health, reproductive health, and safety).

Where prevention breaks down: barriers young women face

PrEP awareness and access gaps

One of the most frustrating realities is that PrEP exists and works, yet many women who could benefit from it never hear
about itor don’t get offered it. Research and policy analyses have highlighted that women are underrepresented in PrEP uptake,
with racial and regional disparities layered on top.

Provider bias and “risk” stereotypes

Some clinicians still associate HIV prevention primarily with men who have sex with men. That outdated mental shortcut means
young womenespecially Black womenmay be less likely to be offered PrEP proactively. If health care waits for a patient to
“look high risk,” it’s already late.

Cost, transportation, privacy

Even when programs exist, life gets in the way: missing work, finding childcare, getting to a clinic, worrying about someone
seeing a medication bottle at home. Prevention strategies work best when services are youth-friendly, confidential, and easy
to accessthink school-based health centers, telehealth, community clinics, and walk-in testing.

What helped Farieda can help anywhere: community-level moves that matter

• Safe housing and social support: stability reduces vulnerability and makes health care doable.
• Youth-centered sexual health education: practical, stigma-free, and honest about relationships and consent.
• Integrated services: STI testing, contraception, HIV testing, PrEP/PEP access, and violence support in one place.
• Normalize testing and PrEP conversations: opt-out testing approaches can reduce stigma and catch infections earlier.
• Address gender-based violence: prevention includes safety planning, legal resources, and trauma-informed care.

The through-line is simple: young women don’t need lectures. They need optionsand systems that make the healthy option the easy one.

Conclusion: Farieda’s story is about HIV, but it’s also about power

Farieda’s story isn’t just a profile of one young woman. It’s a reminder that HIV prevention for young women has to be bigger
than one message, one pamphlet, or one awkward clinic visit.

The science is strong: PrEP, PEP, condoms, routine testing, and effective treatment can dramatically reduce HIV transmission and
support long, healthy lives. But science doesn’t deliver itself. People doclinicians who offer prevention without judgment,
communities that fund and protect services, schools that teach consent and health literacy, and programs that provide safety
when life gets unstable.

If you’re a young woman reading this: you deserve prevention that fits your life. If you’re a parent, educator, clinician, or friend:
the most powerful thing you can do is make support normal and stigma boring.

Medical note: This article is educational and not a substitute for medical advice. If you think you may have been exposed
to HIV within the last 72 hours, seek urgent medical care to ask about PEP. For ongoing prevention options like PrEP, talk with a
qualified health care provider.

Experiences: what “young women and HIV” looks like in real life (beyond the headlines)

When people talk about HIV risk for young women, the conversation often gets flattened into either fear (“Be careful!”) or blame
(“Why didn’t she…?”). But the lived experiences around HIV are usually more complicatedand more ordinarythan either extreme.
Below are common experiences reported by young women, educators, advocates, and clinicians who work in HIV prevention and care.
These aren’t meant to stereotype anyone; they’re meant to show why “just make better choices” is rarely an adequate public health plan.

Experience #1: The “I don’t want to look suspicious” problem. A lot of young women say they avoided asking for an HIV test
or PrEP because they worried someone would judge themparents, partners, even clinic staff. The irony is painful: the very tools that
protect your health can feel like they come with social penalties. One common workaround is asking for “a full panel” or bundling HIV testing
with a routine checkup, so the visit doesn’t feel like a neon sign. Clinics that normalize opt-out screening and speak about HIV the same way
they speak about cholesterol do something radical: they make prevention boring. And boring is good.

Experience #2: Risk isn’t always about your behaviorit can be about your partner’s secrets. Young women in monogamous relationships
sometimes assume they’re automatically “low risk.” But risk can also come from what you don’t know: a partner’s undisclosed HIV status,
a partner’s other partners, or a partner’s inconsistent condom use elsewhere. This is where PrEP can be empowering: it doesn’t require perfect trust,
perfect timing, or perfect communication. It’s prevention that doesn’t collapse if someone else makes a bad decision.

Experience #3: “I can’t take a daily pill” is not lazinessit’s logistics. Daily medication sounds easy until you add real life:
unstable housing, school schedules, childcare, shifting work hours, a phone that gets shut off, or the constant worry that someone will find your meds
and start asking questions. Long-acting options (like injectable PrEP) matter because they reduce the number of daily decision points. Many young women
describe the mental relief of not having to remember a pill every single dayor not having to hide it.

Experience #4: Sexual assault and coercion change the timeline. For survivors, the first hours after an assault can feel like fog,
paperwork, and shockyet HIV prevention is suddenly time-sensitive. Young women who’ve been through this often say that having a clinician calmly explain
PEP (“We can start this today; you don’t have to decide everything right now”) was one of the first moments they felt control return. The lesson here is
not just “PEP exists.” It’s that trauma-informed careclear options, no shaming, rapid accesscan prevent both infection and deeper harm.

Experience #5: Living with HIV today can be medically manageable, but emotionally complicated. Young women living with HIV often describe
the medication routine as doable, but the stigma as exhausting. Some say they feared dating more than the virus itself. This is where U=U can be life-changing:
learning that an undetectable viral load means zero sexual transmission risk can relieve anxiety and help rebuild confidence. Still, it doesn’t erase fear of
disclosure, rejection, or gossipespecially in smaller communities. Support groups, counseling, and peer mentors can be as important as lab results.

Experience #6: The “clinic that gets me” makes all the difference. A youth-friendly clinic doesn’t just have posters with diverse faces.
It has staff who use respectful language, offer choices, protect privacy, and don’t act shocked by normal human behavior. Young women consistently report
better follow-throughtesting, PrEP refills, treatment adherencewhen they feel safe and seen. The systems matter. The tone matters. Sometimes the most effective
intervention is simply making care feel like care.

Farieda’s story resonates because it shows what happens when support is practical, not performative. Prevention and care work best when young women are offered
real tools, real privacy, and real respect. That’s not just compassionateit’s how public health succeeds.

SEO Tags